Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

BRL-101

Alternative Names: BRL-101, BRL 101, BRL101
Latest Update: 2024-07-31
Latest Update Note: Clinical Trial Update

Product Description

BRL-101 is being developed by Bioray Laboratories for the treatment of patients with Transfusion-Dependent beta-Thalassemia (TDT). (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05577312?term=BRL-101&draw=2&rank=1)

Mechanisms of Action: Stem Cell Therapy,CD34

Novel Mechanism: No

Modality: Cell Therapy

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bioray Laboratories
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BRL-101

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: beta-Thalassemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2022-BRL-101

P1

Enrolling by invitation

beta-Thalassemia

2025-08-04

12%
CTR20222413

P2

Recruiting

beta-Thalassemia

None

Recent News Events

Date

Type

Title

09/14/2023

News Article

 Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies

12/15/2022

News Article

 Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerate Speed to Market

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions